Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.98 HKD | +2.80% | -2.38% | +4.49% |
04-15 | Ocumension Therapeutics Completes Phase III Trials for Postoperative Inflammation Drug | MT |
04-15 | Ocumension Therapeutics Announces Phase III Clinical Trial of OT-502 in China | CI |
Official Publications
No official publication found
- Stock Market
- Equities
- 1477 Stock
- News Ocumension Therapeutics
- Official Publications